Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Cartesian Therapeutics Rnac Stock Good For Beginners Price At 6.26 Down 2.03 20260402 Gilt Q4 2025 Earnings Gilat Satellite Networks Ltd. Posts 43 Eps Beat 20260403 Is Frontview Reit Fvr Stock Moving Sideways Price At 15.62 Up 0.61 20260406 Is Ouster Oust Stock Good For Passive Investors Price At 19.28 Down 1.08 20260406 How Does Ally Ally Stock Compare To Competitors Price At 41.78 Up 0.17 20260409 SoYoung SY Breakout Watch Q4 2025 Below Expectations What Nexgen NXE does that makes it resilient Risk Aversion 20260507 How Western WAL differentiates itself from competitors Risk Aversion 20260507 LI Li Auto EPS smashes estimates at 108 vs 00255 but revenue slides 222 YoY China Food Delivery Sector Regulatory Enforcement and AntiCompetition Policy Update TCOM Tripcom notches 48 percent Q4 2025 EPS beat but shares fall 143 percent in todays trading The supply chain story behind Universal ULH earnings Q1 2026 Earnings Fall Short KTWO K2 Capital set to share core operational updates and 2024 outlook in its latest quarterly earnings release RQI Cohen and outlines targeted highyield commercial real estate additions in its latest quarterly earnings report FIGS FIGS Stock Why You Should Buy It Overhead Buying 20260427 PCT PureCycle beats Q4 2025 EPS forecasts handily sending shares 067 percent higher in todays trading The strategic priorities reflected in Green GRBK results Q1 2026 Earnings Beat Estimates Gogoro GGR Annual Recap Gogoro reports 086 per share loss no revenue or analyst estimates Why TD SYNNEX SNX earnings beat or miss matters less than you think SNX TD SYNNEX Q1 2026 Earnings EPS Smashes Estimates by 41 Plains All PAA Q1 2026 Disappoints EPS 039 Below 041 Views JLR and General Motors Pursue 900m Military Truck Contract to Expand Into UK Defence Sector Cerebras IPO Debut TrumpXi Summit Aftermath and Auto Sector ShakeUp Wednesday Market Digest Medpace Holdings MEDP Crushes Q1 2026 Estimates EPS 428 Tops Views Silicon Valley Praises Chinese AI Startup DeepSeek for Breakthrough on Limited Hardware Anthropic Takes Legal Action Against US Defense Department Over National Security Blacklisting Flaherty PFO Stock Analysis Falls 088 Watching 861 20260514 AIxCrypto AIXC Slips 201 Testing 116 Support 20260519 Old National Bancorp Preferred Stock ONBPO Edges Higher as Trading Remains Rangebound Virtus NCV Up 112 Is There More Room to Run 20260520 Toppoint Holdings TOPP Gained 918 Can It Break 091 20260520 Nomad NOMD Reports Strong Q1 2026 Revenue NA EPS Beats Anthropic Private Shares Trigger SecondMarket Frenzy Amid Fraud Concerns Foreign Investors Rotate from Nifty Giants to Indias Small and Midcap Markets Amid Growth Opportunities Hitachi Secures Contract for Signaling System on Mexican Railway Needham Analysts Lower Workday WDAY Price Target Amid Market Caution AsiaPacific Markets Poised for Broad Gains as Oil Retreats on USIran Peace Hopes Compugen Ltd CGEN Q1 2026 Earnings Earnings Miss Slightly but Shares Rally on Upcoming Catalyst WMB Q1 2026 Earnings EPS Miss Weighs on Stock Natural Gas Infrastructure Firm Faces Profitability Headwinds MMI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market ARLO Q1 2026 Earnings Strong EPS Beat Drives Share Price Higher GIL Q1 2026 Earnings Strong EPS Beat Amid Modest Market Response FB Financial Corporation FBK Edges Higher Amid Consolidation Near Key Support Main Street Capital MAIN Edges Higher as YieldFocused Investors Take Notice Cardlytics CDLX Slides as Trading Remains Volatile Near Key Support Levels DTE Energy Debenture DTB Edges Higher Amid Stable Trading Key Levels to Watch Eurovision Victory Sparks Economic Buzz for Bulgaria as Dara Returns Home Innoviz INVZ Q1 2026 Results Miss Estimates EPS 012 vs 009 JPMorganLed Bank Group Tightens Credit Line to KKRs Troubled Private Credit Fund as Losses Deepen Tech Stocks Lift Indices to Fresh Highs as Broader Market Struggles Following Inflation Report Why JJ Believes Its New Psoriasis Pill Icotyde Could Become a Blockbuster Drug